Volvaltrate B(CAS: 1181224-13-4)

Regulatory guidelines for Volvaltrate B include the Classification and Labelling Inventory (CLP) under REACH, as well as FDA and EPA requirements for the handling and sale in the United States. It is classified under GHS as a toxic substance, requiring appropriate safety data sheets (SDS) and labeling to ensure worker protection and environmental safety.

There are several alternatives to Volvaltrate B in synthesis, including the use of isomers or analogs such as Volvaltrate A. Other substitute reagents like benzylamine or other amine derivatives are commonly used depending on the specific application and desired properties of the final product.

The market for Volvaltrate B is currently stable, with increasing research interest in its application in pharmaceutical and chemical processes. Recent trends show a focus on its use in anti-inflammatory and analgesic drugs. Research is also exploring its potential in new therapeutic areas, leading to positive market growth and innovation.

Waste containing Volvaltrate B should be collected in appropriate containers and carefully labeled with the substance name and CAS number. It should then be disposed of through professional waste disposal services that specialize in hazardous waste. Environmental protection measures include ensuring no leakage and proper containment to prevent soil or water contamination.